• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    H

    Hôpital de la Tour

    EST. 1976
    520论文总数
    9,958引用总数

    论文量&引用量时间轴

    机构学者

    论文(520)

    年份
    起
    –
    止
    排序
    1Sirolimus-Eluting Balloon with Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial.
    Christian Spaulding,Florian Krackhardt,Kris Bogaerts,Eltigani Abdelaal,Fernando Alfonso,Carlo Briguori,Leonhard Bruch,Nicholas Cruden,Alexander W Den Hartog,Philippe Garot, Mathieu Godin,David Hildick-Smith,

    BACKGROUND:Implantation of drug eluting stents (DESs) is currently the default approach for percutaneous coronary interventions, but long-term adverse events still exist. An approach with minimal stenting deserves to be assessed in a randomized trial. We studied a novel sirolimus-eluting balloon (SEB) that elutes sirolimus over a 90-day period using a biodegradable polymer microreservoir technology. METHODS:In a multicenter, open-label, randomized trial, we compared an SEB-based strategy with provisional DES with one of systematic DES for de novo lesions in coronary arteries between 2 and 5 mm in diameter. Subjects were randomized 1:1 before percutaneous coronary intervention. The primary end point was target vessel failure, a composite of cardiac death, target vessel-related myocardial infarction, and clinically driven target vessel revascularization. It was tested for noninferiority at 1 year with the use of an absolute margin equal to 50% of the combined event rate at a significance level of 0.025. The primary analysis population included all randomized subjects with completed or attempted percutaneous revascularization, analyzed according to the intention-to-treat principle. A sensitivity analysis was performed on the per-protocol population. RESULTS:Between August 27, 2021, and July 29, 2024, 3323 participants were randomized and treated in 62 sites. Among 1661 participants in the SEB strategy group, bailout stenting was performed in 343 (20.7%). Target vessel failure occurred over 365 days in 88 (5.3%) and 73 (4.4%) participants in the SEB and the systematic DES strategy groups, respectively (risk difference, 0.91% [95% CI -0.55% to 2.38%]; 1-sided P=0.02 for noninferiority with a 2.44% noninferiority margin). Clinically driven target vessel revascularization occurred more frequently in the SEB strategy group (3.3% versus 2.1%; risk difference, 1.22% [95% CI, 0.11%-2.33%). Safety events, including lesion thrombosis, were low and similar in both groups. Although the results of the per-protocol population (3194 participants, 96%) did not confirm noninferiority (upper boundary of the 95% CI, 2.63; P=0.04), they were similar to the intention-to-treat results in both magnitude and direction. CONCLUSIONS:At 1 year, in the primary intention-to-treat analysis population, a strategy of percutaneous coronary intervention with SEB and provisional DES was noninferior to the systematic use of DES for the primary end point of target vessel failure. The per-protocol population sensitivity analysis did not confirm noninferiority. Clinically driven target vessel revascularization occurred more frequently in the SEB strategy group. At 5 years, target vessel failure will be tested again for noninferiority and for superiority if noninferiority is achieved. REGISTRATION:URL: https://www.clinicaltrials.gov; Unique identifier: NCT04859985.

    2026Circulation(2026)引用:2
    引用
    AI阅读
    加入学术空间
    2Multicenter Evaluation of Planning Quality in Intracranial Stereotactic Radiotherapy for Brain Metastases
    Sara Abdollahi, Rachid Boucenna, Cécile Chatelain, Nathan Corradini, Marie Fargier-Voiron, Vincent Fave, Juan Garcia, Sarah Ghandour,Matthias Guckenberger, Käthy Haller, Martin Härtig, Tanja Hertel,

    Background and purpose:Stereotactic radiotherapy (SRT) is a standard approach for treating multiple brain metastases. However, variation in planning practices may impact treatment quality. This study assessed planning consistency and dose-volume-based outcomes across radiation oncology centers. Materials and methods:A Computed Tomography (CT) scan of an anthropomorphic phantom with structure set was distributed to participating centers. Each center created SRT plans as for a clinical case. Dose distributions were evaluated based on Planning Target Volume (PTV) coverage (V100% (PTV)), dose to 95% of Gross Target Volume (GTV) volume (D95% (GTV)), maximal PTV dose (Dmax), conformity index (CI), gradient index (GI), brain volume receiving different percentages of the prescribed dose, and doses delivered to 0.035 cm3 and 0.5 cm3 of the brainstem. Results:Twenty-four centers, using 30 treatment units, submitted plans. The V100% (PTV) ranged from 95% to 100%, with Dmax between 110% and 150% of the prescribed dose. Mean GTV dose ranged from 110% to 135%, and 81% of GTVs had D95% between 110% and 120%. High conformity was achieved in 74% of plans (CI < 1.1), while 67% had a GI between 3.4 and 5. All plans met clinical dose constraints for the brainstem and uninvolved brain. Conclusion:This interinstitutional comparison demonstrated high plan quality and adherence to critical organ constraints, despite variability in planning strategies. These findings support nationwide planning and quality assurance standards to ensure consistently high-quality SRT.

    2026Physics and imaging in radiation oncology(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3Gluteus Medius and Minimus Tears Open Repair/Reconstruction
    Panayiotis Christofilopoulos,Georgios Kyriakopoulos,Eustathios Kenanidis
    2026Arthroscopy(2026)引用:1
    引用
    AI阅读
    加入学术空间
    4Navigating the Next Decade of Hip Preservation: Commentary on an Article by Jeffrey J. Nepple, MD, MS, Et Al.: " Survivorship of Femoroacetabular Impingement Surgery at Mean 10-Year Follow-up. A Prospective, Multicenter Cohort Study ".
    Michael Wettstein,Panayiotis Christofilopoulos
    2026The Journal of bone and joint surgery American volume(2026)
    引用
    AI阅读
    加入学术空间
    5Sustained Blood Pressure Reduction Associated with Percutaneous Auricular Vagus Nerve Stimulation in Hypertensive Chronic Pain Patients: a Retrospective Dual-Center Analysis
    Laurenz Berger,Rudolf Likar,Christophe Perruchoud,Stefan Kampusch,Van Hoang Le,Klaus Zeiner,Caroline Stremnitzer,Francesco Moscato, Max Haberbusch

    BackgroundHypertension is a major risk factor for cardiovascular diseases, affecting over 1.28 billion adults worldwide, with nearly 46% remaining undiagnosed or untreated. Auricular vagus nerve stimulation (aVNS) has emerged as a promising non-invasive neuromodulation approach for autonomic regulation, yet its effects on blood pressure (BP) remain underexplored.ObjectiveThe effects of aVNS on blood pressure in chronic pain patients were evaluated, with a specific focus on differential responses by hypertensive status and antihypertensive treatment.MethodsThis retrospective dual-center study analyzed the impact of aVNS on BP in 24 chronic pain patients [mean age 48.5 (9.1) years; 75% female], categorized into non-hypertensive (n = 13) and hypertensive (n = 11) individuals. The hypertensive cohort was further stratified into patients receiving pharmacological hypertension treatment (n = 5) and those untreated (n = 6). Patients received aVNS over an 8-week treatment period, followed by a 4-week follow-up.ResultsOver an 8-week treatment period, hypertensive patients exhibited significant reductions in systolic BP [−10.7 (2.9) mmHg, p = 0.0003] and diastolic BP [−5.8 (2.0) mmHg, p = 0.0357], while non-hypertensive individuals showed no significant BP changes. Subgroup analysis revealed that BP reductions were most robust and consistent in untreated hypertensive patients (SBP: −11.0 mmHg, p = 0.001), whereas patients on antihypertensive medication showed greater variability. Mean arterial pressure (MAP) declined significantly in hypertensive individuals [−9.3 (6.7) mmHg, p = 0.0022]. In contrast, no significant changes were observed in heart rate or heart rate variability [e.g., heart rate: −0.9 (1.8) beats/min; root mean square of successive differences in normal RR intervals: −12.8 (9.0) ms at week 12, both p = 1.0000], suggesting preserved autonomic stability.ConclusionsaVNS may be associated with BP reductions in hypertensive patients particularly those not receiving pharmacological treatment, with minimal effects in normotensive individuals. These retrospective findings suggest a potential sustained benefit in patients with comorbid chronic pain and support further investigation through prospective, sham-controlled trials to confirm efficacy and clarify underlying mechanisms.

    2026Frontiers in cardiovascular medicine(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 520 篇论文

    合作机构(100)

    日内瓦大学医院合作论文 53
    洛桑大学医院合作论文 18
    日内瓦大学合作论文 16
    Centre Hospitalier privé Saint Grégoire合作论文 14
    苏黎世大学合作论文 14
    伯尔尼大学合作论文 12
    俄勒冈健康与科学大学合作论文 10
    巴黎医院公共援助合作论文 9
    伯尔尼大学医院合作论文 9
    Valdoltra Orthopedic Hospital合作论文 9

    机构统计